Impact of Clostridioides difficile infection on the outcome of patients receiving a hematopoietic stem cell transplantation
Author(s) -
Sarah Weber,
Sebastian Scheich,
Aaron Magh,
Sebastian Wolf,
Julius C. Enßle,
Uta Brunnberg,
Claudia Reinheimer,
Thomas A. Wichelhaus,
Volkhard A. J. Kempf,
Johanna Kessel,
Maria J. G. T. Vehreschild,
Hubert Serve,
Gesine Bug,
Björn Steffen,
Michael Hogardt
Publication year - 2020
Publication title -
international journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.278
H-Index - 89
eISSN - 1878-3511
pISSN - 1201-9712
DOI - 10.1016/j.ijid.2020.08.030
Subject(s) - clostridioides , hematopoietic stem cell transplantation , medicine , transplantation , stem cell , outcome (game theory) , oncology , biology , genetics , mathematics , mathematical economics
Clostridioides difficile infections (CDI) are common in autologous (auto-HSCT) or allogenic hematopoietic stem cell transplant (allo-HSCT) recipients. However, the impact of CDI on patient outcomes is controversial. We conducted this study to examine the impact of CDI on patient outcomes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom